|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
51,320,000 |
Market
Cap: |
4.72(B) |
Last
Volume: |
548,324 |
Avg
Vol: |
491,730 |
52
Week Range: |
$71.24 - $93.49 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 438 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
22,518 |
91,806 |
Total Sell Value |
$0 |
$0 |
$1,982,727 |
$7,138,305 |
Total People Sold |
0 |
0 |
4 |
9 |
Total Sell Transactions |
0 |
0 |
6 |
33 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Scanlan Jacqueline |
SVP, Global Human Resources |
|
2020-03-06 |
4 |
AS |
$100.50 |
$130,550 |
D/D |
(1,299) |
4,708 |
|
-10% |
|
Scanlan Jacqueline |
SVP, Global Human Resources |
|
2020-03-06 |
4 |
OE |
$38.43 |
$49,921 |
D/D |
1,299 |
6,007 |
|
- |
|
Kroll Mark W |
Director |
|
2019-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
870 |
22,747 |
|
- |
|
Bolorforosh Said |
EVP, Chief Technology Officer |
|
2019-11-11 |
4 |
S |
$118.27 |
$40,094 |
D/D |
(339) |
1,977 |
|
- |
|
Gelbman Ronald G |
Director |
|
2019-11-11 |
4 |
S |
$118.26 |
$2,001,669 |
D/D |
(16,926) |
48,384 |
|
- |
|
Gelbman Ronald G |
Director |
|
2019-11-11 |
4 |
OE |
$35.50 |
$666,295 |
D/D |
16,926 |
65,310 |
|
- |
|
Meelia Richard J |
Director |
|
2019-11-11 |
4 |
S |
$118.15 |
$776,600 |
D/D |
(6,573) |
30,067 |
|
- |
|
Meelia Richard J |
Director |
|
2019-11-11 |
4 |
OE |
$45.45 |
$298,743 |
D/D |
6,573 |
36,640 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-10-29 |
4 |
AS |
$122.69 |
$177,655 |
D/D |
(1,448) |
10,411 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-10-29 |
4 |
AS |
$122.69 |
$29,078 |
D/D |
(237) |
2,452 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-10-28 |
4 |
AS |
$120.33 |
$138,981 |
D/D |
(1,155) |
11,859 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-10-28 |
4 |
AS |
$120.33 |
$12,033 |
D/D |
(100) |
2,689 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-10-25 |
4 |
AS |
$119.87 |
$1,349,634 |
D/D |
(11,231) |
13,014 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-10-25 |
4 |
OE |
$34.21 |
$384,213 |
D/D |
11,231 |
24,245 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-10-25 |
4 |
AS |
$120.32 |
$175,186 |
D/D |
(1,456) |
2,789 |
|
- |
|
Goldstein Dan |
VP, Corporate Controller |
|
2019-10-25 |
4 |
OE |
$34.21 |
$49,810 |
D/D |
1,456 |
4,245 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,621 |
14,759 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-10-09 |
4 |
AS |
$122.50 |
$1,318,117 |
D/D |
(10,633) |
13,138 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-10-09 |
4 |
AS |
$122.72 |
$2,815,079 |
D/D |
(22,704) |
13,014 |
|
- |
|
Scanlan Jacqueline |
SVP, Global Human Resources |
|
2019-10-09 |
4 |
AS |
$122.37 |
$360,539 |
D/D |
(2,909) |
4,695 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-10-08 |
4 |
AS |
$122.34 |
$1,086,746 |
D/D |
(8,883) |
23,771 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-10-08 |
4 |
AS |
$122.34 |
$2,318,343 |
D/D |
(18,950) |
35,718 |
|
- |
|
Scanlan Jacqueline |
SVP, Global Human Resources |
|
2019-10-08 |
4 |
AS |
$122.34 |
$280,770 |
D/D |
(2,295) |
7,604 |
|
- |
|
Burke Willaim P |
EVP, Chief Financial Officer |
|
2019-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
41,654 |
54,668 |
|
- |
|
Basil Michelle L |
EVP and General Counsel |
|
2019-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
19,516 |
32,654 |
|
- |
|
1310 Records found
|
|
Page 10 of 53 |
|
|